These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26179289)

  • 1. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy.
    Singal G; Upadhyay GA; Borgquist R; Friedman DJ; Chatterjee NA; Kandala J; Park MY; Orencole M; Dec GW; Picard MH; Singh JP; Mela T
    Pacing Clin Electrophysiol; 2015 Oct; 38(10):1192-200. PubMed ID: 26179289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy.
    Daly DD; Maran A; Hyer JM; Funke F; Waring A; Cuoco FA; Sturdivant JL; Leman RB; Gold MR
    Pacing Clin Electrophysiol; 2016 Aug; 39(8):863-9. PubMed ID: 27197959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Resynchronization Therapy in CKD Stage 4 Patients.
    Höke U; Khidir MJ; van der Velde ET; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1740-8. PubMed ID: 26408549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function and mortality following cardiac resynchronization therapy.
    Lin G; Gersh BJ; Greene EL; Redfield MM; Hayes DL; Brady PA
    Eur Heart J; 2011 Jan; 32(2):184-90. PubMed ID: 21068051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia and its association with clinical outcome in heart failure patients undergoing cardiac resynchronization therapy.
    Venkateswaran RV; Freeman C; Chatterjee N; Kandala J; Orencole M; Vegh EM; Parks KA; Cowburn PJ; Dec GW; Singh JP; Borgquist R
    J Interv Card Electrophysiol; 2015 Dec; 44(3):297-304. PubMed ID: 26453528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.
    Friedman DJ; Singh JP; Curtis JP; Tang WHW; Bao H; Spatz ES; Hernandez AF; Patel UD; Al-Khatib SM
    J Am Coll Cardiol; 2015 Dec; 66(23):2618-2629. PubMed ID: 26670062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction.
    Moreira RI; Cunha PS; Rio P; da Silva MN; Branco LM; Galrinho A; Feliciano J; Soares R; Ferreira RC; Oliveira MM
    J Interv Card Electrophysiol; 2018 Apr; 51(3):237-244. PubMed ID: 29460235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
    Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
    Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and Clinical Outcomes of Transient Responders to Cardiac Resynchronization Therapy.
    Ichibori H; Fukuzawa K; Kiuchi K; Matsumoto A; Konishi H; Imada H; Hyogo K; Kurose J; Tatsumi K; Tanaka H; Hirata KI
    Pacing Clin Electrophysiol; 2017 Mar; 40(3):301-309. PubMed ID: 28083969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Renal Function on Survival After Cardiac Resynchronization Therapy.
    Kpaeyeh JA; Divoky L; Hyer JM; Daly DD; Maran A; Waring A; Gold MR
    Am J Cardiol; 2017 Jul; 120(2):262-266. PubMed ID: 28545627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial.
    Boidol J; Średniawa B; Kowalski O; Szulik M; Mazurek M; Sokal A; Pruszkowska-Skrzep P; Kukulski T; Kalarus Z; Lenarczyk R;
    Europace; 2013 Jun; 15(6):835-44. PubMed ID: 23487543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
    Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M
    Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to Cardiac Resynchronization Therapy Across Chronic Kidney Disease Stages.
    Ter Maaten JM; Martens P; L'hoyes W; Maass AH; Damman K; Dupont M; Mullens W
    J Card Fail; 2019 Oct; 25(10):803-811. PubMed ID: 31323302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin levels predict clinical outcomes in chronic kidney disease (CKD) patients undergoing cardiac resynchronization therapy.
    Uchikawa T; Shimano M; Inden Y; Murohara T
    Intern Med; 2014; 53(6):555-61. PubMed ID: 24633024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female gender is associated with a better outcome after cardiac resynchronization therapy.
    Leyva F; Foley PW; Chalil S; Irwin N; Smith RE
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):82-8. PubMed ID: 21214589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.